Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,897
datasets available to search
ShareScore release 0.9.0
Dataset results
2,897 results for “adjuvants”
D-FAB-POUR Trial: Dexmedetomidine vs Fentanyl as Adjuvants to Bupivacaine on Postoperative Urinary Retention
ClinicalTrials.gov study NCT07117565. IPD Sharing: YES. Countries: 1. Publications: 0.
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
ClinicalTrials.gov study NCT04305236. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
ClinicalTrials.gov study NCT06087640. IPD Sharing: YES. Countries: 21. Publications: 0.
Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy
ClinicalTrials.gov study NCT03205033. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive I
ClinicalTrials.gov study NCT00464646. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial
ClinicalTrials.gov study NCT05719649. IPD Sharing: NO. Countries: 0. Publications: 31.
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
ClinicalTrials.gov study NCT01045941. IPD Sharing: Not stated. Countries: 1. Publications: 3.
UVX as an Adjuvant in the Treatment of Fungal Keratitis
ClinicalTrials.gov study NCT03138785. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a
ClinicalTrials.gov study NCT03008122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
ClinicalTrials.gov study NCT00527982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free
ClinicalTrials.gov study NCT00002359. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain
ClinicalTrials.gov study NCT01840345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
ClinicalTrials.gov study NCT02580279. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
ClinicalTrials.gov study NCT02480114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy
ClinicalTrials.gov study NCT01939223. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
ClinicalTrials.gov study NCT01645059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
the Effect of Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy
ClinicalTrials.gov study NCT05920070. IPD Sharing: YES. Countries: 0. Publications: 6.
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
ClinicalTrials.gov study NCT01394211. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation
ClinicalTrials.gov study NCT01682213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neo-Adjuvant Endocrine Therapy in Post-Menopausal Hormone Receptor Positive HER 2 Neu Negative Node Positive Early-Stage Breast Cancer Patients With One Year of Letrozole.
ClinicalTrials.gov study NCT07394946. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.